This correlation is strengthened by the findings indicating that mice deficient in Cers6 not only exhibit reduced C16:0 ceramide levels but are also protected from HFD‐induced obesity and glucose intolerance (Turpin et al., 2014). The gene discussed is CERS6; the disease is Glucose intolerance.